EPH71 Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.602
https://www.valueinhealthjournal.com/article/S1098-3015(25)00727-2/fulltext
Title :
EPH71 Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)00727-2&doi=10.1016/j.jval.2025.04.602
First page :
Section Title :
Open access? :
No
Section Order :
10365